A population model of prostate cancer incidence. Stat Med 2006 Aug 30;25(16):2846-66
Date
01/07/2006Pubmed ID
16397859DOI
10.1002/sim.2257Scopus ID
2-s2.0-33746903130 (requires institutional sign-in at Scopus site) 42 CitationsAbstract
Introduction of screening for prostate cancer using the prostate-specific antigen (PSA) marker of the disease led to remarkable dynamics of the incidence of the disease observed in the last two decades. A statistical model is used to provide a link between dissemination of PSA and the observed transient population responses. The model is used to estimate lead time, overdiagnosis and other relevant characteristics of prostate cancer screening.
Author List
Tsodikov A, Szabo A, Wegelin JAuthor
Aniko Szabo PhD Professor in the Data Science Institute department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Age of OnsetAged
Biometry
Humans
Male
Mass Screening
Middle Aged
Models, Statistical
Population
Prostate-Specific Antigen
Prostatic Neoplasms
SEER Program
Time Factors
United States